Esperion Therapeutics
ESPR
#6599
Rank
โ‚น76.73 B
Marketcap
โ‚น297.77
Share price
-0.63%
Change (1 day)
255.56%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: โ‚น76.73 Billion

As of June 2026 Esperion Therapeutics has a market cap of โ‚น76.73 Billion. This makes Esperion Therapeutics the world's 6599th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น76.73 B-10.75%
2025โ‚น85.97 B123.09%
2024โ‚น38.53 B36.15%
2023โ‚น28.30 B-25.48%
2022โ‚น37.98 B67.6%
2021โ‚น22.66 B-54.01%
2020โ‚น49.27 B-57.86%
2019โ‚น116.92 B35.52%
2018โ‚น86.28 B-21.66%
2017โ‚น110.13 B473.95%
2016โ‚น19.18 B-42.39%
2015โ‚น33.30 B-36.12%
2014โ‚น52.14 B300.4%
2013โ‚น13.02 B

End of Day market cap according to different sources

On Jun 28th, 2026 the market cap of Esperion Therapeutics was reported to be:

โ‚น77.14 Billion
by Nasdaq info icon info icon
โ‚น77.22 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚น13.129 T 17,010.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น6.261 T 8,060.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
โ‚น285.63 B 272.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚น110.85 B 44.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น430.09 B 460.51%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น1.053 T 1,273.20%๐Ÿ‡บ๐Ÿ‡ธ USA